|
⚲
|
| Keyboard |
| Wilson Jason Douglas
✚
|
|
|---|---|
| CIK # | 0001662395 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001662395] | |
| 4 | [0001662395] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Wilson Jason Douglas | |
| Reata Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2020-01-02 | Grant | 15,000 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-12-16 | Conversion | 10,000 | ||
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-12-16 | Conversion | 5,600 | ||
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-12-16 | Option exercise | 10,000 | $11.00 | 110,000 |
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2019-12-16 | Option exercise | 10,000 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 400 | $206.89 | 82,756 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 200 | $205.08 | 41,016 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 1,480 | $204.54 | 302,719 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 2,320 | $203.60 | 472,352 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 3,400 | $202.51 | 688,534 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 1,300 | $201.65 | 262,145 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 500 | $200.17 | 100,085 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Sell | 400 | $207.48 | 82,992 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Conversion | 10,000 | ||
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-12-16 | Conversion | 5,600 | ||
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2019-11-11 | Grant | 17,250 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-10-17 | Conversion | 10,000 | ||
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-10-17 | Conversion | 10,000 | ||
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-10-17 | Option exercise | 10,000 | $11.00 | 110,000 |
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2019-10-17 | Option exercise | 10,000 | $0.00 | |
| showing 20 of 126 most recent transactions | |||||